审稿指南/Information for Reviewers
可下载PDF文件查看。
The content is available for download as a PDF.Zentime志愿审稿福利/Benefits for Volunteer Reviewers
同行评审是出版流程中至关重要的一环,能够确保Zentime发文质量始终处于优质上乘。审稿人则是审稿工作的基石,兢兢业业、不求回报,Zentime为审稿者设身处地,正在通过以下措施努力提升审稿工作的认可度与成就感:
a. 符合条件的审稿人未来向任何Zentime旗下期刊投递文章时,可以豁免或减免版面费(APC)。
b. 审稿流程结束后,审稿人将会收到个人审稿证书。
c. 审稿人会被列入期刊年度审稿人致谢名单。
d. 贡献突出者将有资格获得杰出审稿人奖。
Peer review is an essential part in the publication process, which ensures the paper published in Zentime maintains high quality, and reviewers are the cornerstone of the peer review process. Reviewing is routinely an unseen and unrewarded task. We are striving to recognize the efforts of reviewers by the following measures.
a. The eligible reviewers can enjoy a waiver or reduction in the article processing charge (APC) of a future submission to any Zentime journal.
b. The reviewer will receive an individual reviewer certificate after the review process.
c. The reviewers are included in the journal’s annual acknowledgment of reviewers.
d. The reviewers with great contributions will be considered eligible for the journal’s outstanding reviewer award.
欢迎加入Zentime审稿人库/Invitation to Join Zentime Volunteer Reviewer Database
如果您有兴趣参与Zentime旗下某本或多本期刊文章的审稿工作,请在以下网站注册并提供您的联系信息,包括您的机构隶属关系、个人简历,以及5-6个与您专业领域相关的关键词:
一旦审核通过,我们将发送通知给您。
If you are interested in reviewing articles for one or more of our journals, please provide your contact details, including your institutional affiliation, a short CV, and 5-6 keywords in line with your expertise for the registration in following website:
We will send you a notification once approved.
审稿邀请/Invitation to Review
提交给Zentime的稿件至少由两位专家审阅。审稿人须评估稿件质量并提供评审意见,反馈接受、修改或是拒稿建议。
具体而言,受邀审稿人应:
a. 根据自身专业知识、稿件标题与摘要,判断是否接受或拒绝邀请;
b. 在适当情况下推荐其他审稿人;
c. 如果无法按时完成审稿,及时提出延期申请;
d. 若有他人如同事或学生一同参与审稿,请告知我们。
在评审环节中,审稿人应:
a. 为稿件提供一个总体建议(可接受、小修或大修、拒稿);
b. 评估稿件的原创性、重要性、表达质量、科学严谨性、读者兴趣、整体价值以及英语语言使用;
c. 审查稿件的参考文献列表,检查有无不正确或不恰当的引用;
d. 提供详细且有建设性的审稿报告/评论;
e. 若审稿中的稿件与任何已发布或先前提交的内容有实质性相似,应提醒编辑。
Manuscripts submitted to Zentime are reviewed by at least two experts. Reviewers are asked to evaluate the quality of and make comments on the manuscript and to provide a recommendation to the editor on whether a manuscript shall be accepted, needs revisions or should be rejected.
Specifically, invited reviewers should:
a. Accept or decline any invitations quickly, based on her/his own expertise, the manuscript title and abstract;
b. Recommend alternative reviewers if appropriate;
c. Request an extension if the review cannot be completed in due time;
d. Let us know if anyone else, such as a colleague or student has participated in the review.
As part of the assessment, reviewers should:
a. Provide an overall recommendation for the manuscript (can be accepted, requires minor or major revisions or should be rejected);
b. Rate the originality, significance, quality of the presentation, scientific soundness, interest to the readers, overall merit and English language of the manuscript;
c. Go through the reference list of the manuscript and check if there are incorrect or inappropriate citations;
d. Provide detailed and constructive review report/comments;
e. Alert editors that the manuscript under review is substantially similar to any published or previously submitted content.
潜在利益冲突/Potential Conflicts of Interests
Zentime审稿人应与作者之间没有利益冲突,并熟悉他们所审阅稿件涉及的研究领域。除了这一预防措施外,审稿人还必须披露与该论文有关的任何潜在冲突,或在必要时终止审稿。编辑在做出决定时会综合考虑以上信息。
如果存在可能对审稿报告产生积极或消极影响的利益冲突,审稿人应告知期刊编辑。编辑部会在发送邀请前进行尽可能全面的核查,我们非常感谢审稿人在此事项上的合作。如果审稿人受邀评审此前在其他期刊审阅过的稿件,应告知我们该稿件与之前版本相比是否有所改进。
We seek reviewers for Zentime who do not have conflicts of interest with the authors and are familiar with the research area involved in the manuscripts they reviewed. In addition to this precaution, reviewers are required to disclose any potential conflicts with the evaluation of the paper, or withdraw their services for that manuscript if necessary, and this information is taken into account by the editors when decisions are made.
Reviewers should inform the journal editor if there is a conflict of interest that may cause prejudice to the review report, either in a positive or negative way. Despite the editorial office will check as far as possible before sending the invitation, we still greatly appreciate the cooperation from the reviewers in this matter. In the case of being invited to assess a manuscript that they previously reviewed for another journal, reviewers should feel free to let us know if the manuscript has been improved or not compared to the previous version.
保密性和匿名性/Confidentiality and Anonymity
审稿人应对文章摘要和主要内容保密。如果审稿人希望学生或同事完成审稿,必须告知编辑部。
Zentime采用单盲同行评审的流程,审稿人应注意避免在评论中向作者透露自己的身份。
Reviewers should keep the major content of the manuscript confidential, including the abstract. Reviewers must inform the Editorial Office if they would like a student or colleague to complete the review.
Zentime adopts the single-blind peer review process. Reviewers should be careful enough to not reveal their identities to the authors in their comments.
及时提交审稿意见/Timely Review Comments
Zentime旨在为作者以及科学界提供高效率高质量的出版服务。我们感激审稿人能及时提供审稿报告来协助我们。如果您需要延长审稿周期,请联系编辑部。
Zentime aims to provide an efficient and high-quality publishing service to authors as well as the scientific community.
We appreciate reviewers to assist us by providing review reports in a timely manner. Please contact the editorial office if you require an extension to the review deadline.
同行评审流程/Peer-Review Procedure
所有投递至我社期刊的稿件,包括研究文章、综述文章和研究简报,都将进行严格彻底的同行评审。撤稿和勘误也可由编辑酌情进行同行评审。
为了节省作者和审稿人的时间,只有符合我们初审标准的稿件才会送至外审,这一决定由期刊管理编辑做出。那些被我们的编辑认为总体质量不足或不适当的文章将被直接拒稿,不进行同行评审。
此外,我们会通过Turnitin、Cross check或iThenticate评估稿件的原创性。
之后,编辑部将发起由专家执行的同行评审,并为每篇稿件收集至少两份的审稿报告(审稿由外部专家或编委完成)。在做出最终决定前,作者需不断完善稿件(如果必要,会进行第二轮的同行评审)。
最终决定将由学术编辑(通常是期刊的主编/编辑委员会成员或特刊的客座编辑)做出。录用文章将进行编修和英文润色。
对于这里未给出解答的相关问题,审稿人可使用网页反馈(Feedback)联系我们,或发送电子邮件至 editorialoffice@zentimecorp.com 。
All manuscripts, including Research articles, Reviews, and Brief Communications, sent for publication in our journals are strictly and thoroughly peer-reviewed by the expert reviewers. Retraction and Erratum may also be peer-reviewed at the discretion of the editors.
To save time for both authors and peer-reviewers, only those papers that seem most likely to meet our publication criteria are sent for formal expert review, which is decided by Managing Editor of the journal. Those papers judged to be insufficient in general interest or inappropriate by our editors are directly rejected without external review.
Furthermore, the originality of the manuscript is assessed (Turnitin, Cross check or iThenticate) to screen the qualified papers.
Later, Editorial Office will organize the peer-review process performed by independent experts and collect at least two review reports per manuscript. The authors are asked for adequate revisions (with a second round of peer-review if necessary) before a final decision is made.
The final decision will be made by the academic editor (usually the Editor-in-Chief/Editorial Board Member of a journal or the Guest Editor of a Special Issue). Accepted articles will be copy-edited and English-edited.
For any general questions and comments about the peer-review and editorial procedures that are not addressed here, reviewers are encouraged to contact us using the feedback links or send e-mail to editorialoffice@zentimecorp.com.
在线审稿/Online Manuscript Review
我们要求审稿人通过Zentime在线系统上传审稿意见。
We ask peer-reviewers to upload their review comments via our online system.
稿件评估/Manuscript Evaluation
建议审稿人从以下方面评估稿件质量:
1. 原创性/新颖性:科学问题是否原创且定义明确?结果相比当前已有知识是否具有进步意义?
2. 重要性:结果解释是否恰当?是否具有重要性?所有结论是否合理,是否具备结果的有力支撑?假设和推测是否经过仔细检验?
3. 呈现质量:文章撰写方式是否恰当?数据分析逻辑是否清晰?结果呈现是否符合高质量高标准?
4. 科学严谨:研究设计是否正确,技术是否可靠?分析是否采用最高技术标准执行?数据是否足够稳健以得出结论?方法、工具、软件和试剂的描述是否足够详细,可供其他研究者复制结果?
5. 读者兴趣:文章结论是否可以引起读者阅读兴趣?文章将会吸引广泛读者群,还是限于少数?(详情敬请参考各个期刊的目标和范围)
6. 整体价值:发布这篇稿件是否具备较高的总体价值?文章是否使得当前学术更进一步?作者是否通过合理可靠的实验解答了一个至关重要且长期存在的问题?
7. 英语写作:英语语言是否恰当且易于理解?
提交给Zentime的稿件应当遵从公认的出版伦理守则:
1. 稿件应只报告以前未提交或发表过的结果,即使仅为部分结果也应如此。
2. 稿件必须原创,未经恰当引用,不得重复使用其他来源的文本。
3. 在报告人类受试者或动物的实验时,作者应提供一份具有批准号和和伦理审查委员会(IRB)批准报告的伦理声明。
4. 当报告一项临床试验时,必须在公认的国际临床试验注册中心(如ClinicalTrials.gov和ISRCTN注册中心)注册,作者应提供注册中心的名称、试验编号和试验URL。
如果审稿人在审稿过程中发现任何伪造、剽窃或其他任何与文章相关的学术不端行为,应立即知会编辑部。
The reviewers are suggested to assess the following aspects of the manuscript:
1. Originality/Novelty: Is the scientific question original and well defined? Are the results advanced compared to current knowledge?
2. Significance: Are the results interpreted appropriately? Are they significant? Are all the conclusions justified and sufficiently supported by the results? Are the hypotheses and speculations carefully tested?
3. Quality of Presentation: Is the article written in an appropriate way? Are the data and analyses presented logically? Are the results presented with high standards?
4. Scientific Soundness: Is the study correctly designed and technically sound? Are the analyses performed with the highest technical standards? Are the data robust enough to draw the conclusions? Are the methods, tools, software, and reagents described with sufficient details to allow another researcher to reproduce the results?
5. Interest to the Readers: Are the conclusions interesting for the readership of the Journal? Will the paper attract a wide readership, or only limited readers? (Please see the Aims and Scope of the journal for details)
6. Overall Merit: Is there an overall benefit to publishing this manuscript? Does the work provide an advance towards the current knowledge? Have the authors addressed an important long-standing question with reasonable experiments?
7. English Writing: Is the English language appropriate and understandable?
Manuscripts submitted to Zentime should meet the standards of publication ethics:
1. Manuscripts should only report results that have not been submitted or published before, even in part.
2. Manuscripts must be original and should not re-use text from another source without appropriate citation.
3. When reporting experiments on human subjects or animals, the authors should provide an ethics statement with approval number(s) and the Institutional Review Board (IRB) Approval Report/Ethic Committee Report.
4. When reporting a clinical trial, which must be registered in a recognized international registry (e.g., ClinicalTrials.gov and ISRCTN Register), the authors should provide the name of the registry, the trial number, and the trial URL.
If reviewers are aware of such scientific misconduct or fraud, plagiarism or any other unethical behaviors related to the manuscript, they should raise concern with the editors immediately.